Journal of Diabetes

Article	Citations
The Relationship Between Glycated Albumin and Time in Tight Range in Type 2 Diabetes	197
Chronic glycemic control influences the relationship between acute perioperative dysglycemia and perioperative outcome	189
Ubiquitin‐conjugating enzyme E2 for regulating autophagy in diabetic cardiomyopathy: A mini‐review	80
Issue Information	75
Association of methylation risk score with incident type 2 diabetes mellitus: A nested case–control study	54
Issue Information	49
Associations of Stressful Life Events With Diabetes Incidence in China: Insights From the China Kadoorie Biobank	42
A novel nonsense mutation c.747C>G in the NEUROD1 gene detected within a Chinese family affected by maturity‐onset diabetes of the young type 6	38
Commentary on CDC data showing an increased risk for pediatric diabetes with COVID‐19 infection	37
Does Metabolic Status Associate With IVF Outcomes in Women Within Similar Body Mass Index Category: Evidence From a Large Cohort Study	36
Dickkopf1 as a Potential Biomarker in Polycystic Ovary Syndrome and Insulin Resistance: A Cross‐Sectional Study	30
Changes in dietary intake of aspartic acid during and after intermittent fasting correlate with an improvement in fasting glucose in overweight individuals	29
Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial	28
Effects of FTO Gene rs9939609 and rs17817449 Polymorphisms on Insulin Resistance in Turkish Children With Obesity	28
Clinical and genetic characteristics of maturity‐onset diabetes of the young type 13: A systematic review of the literature	28
A Review of micro RNAs changes in T2DM in animals and humans	27
	26
Patterns of new glucagon‐like peptide‐1 receptor agonist use in patients with type 2 diabetes during 2014–2019 from a US database: prescriber and patient characteristics	26
Correlation of ACR and TcPO2 in diabetic kidney disease patients: A pilot study	26
Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes	26
CircMAP3K5 promotes cardiomyocyte apoptosis in diabetic cardiomyopathy by regulating miR‐22‐3p/DAPK2 Axis	26
Response to Commentary on “Sleep Phenotypes, Genetic Susceptibility, and Risk of Obesity in Patients With Type 2 Diabetes: A National Prospective Cohort Study”	25
Osteoarthritis and risk of type 2 diabetes: A two‐sample Mendelian randomization analysis	25
Corrigendum	24
	24

Potential mechanisms of metabolic reprogramming induced by ischemia–reperfusion injury in diabetic myocardium	23
Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus	23
Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial	23
Sleeve gastrectomy improved microvascular phenotypes from obesity cohort, detected with optical coherence tomography angiography	23
	22
FSH regulates glucose‐stimulated insulin secretion: A bell‐shaped curve effect	22
Associations of maternal serum ferritin levels across gestation with gestational diabetes mellitus: A longitudinal cohort study	22
The Role of Negative Pressure Therapy in Diabetic Foot Ulcer: A Meta‐Analysis	21
Pain Modulation and Central Sensitization in Painful Diabetic Peripheral Neuropathy: Updated Narrative Review and Future Directions	21
Overview of oxidative stress and inflammation in diabetes	21
Sex differences in the risk of arterial stiffness among adults with different glycemic status and modifications by age	21
Issue Information	20
Comment on: “Prevalence and Influencing Factors of Malnutrition in Diabetic Patients: A Systematic Review and Meta‐Analysis”	20
Response to “Commentary on factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV re	19
A novel index, Chinese visceral adiposity index is closely associated with urinary albumin‐creatinine ratio in Chinese community adults, especially in hypertensive or hyperglycemic population: Results	19
Interactive correlations between artificial light at night, health risk behaviors, and cardiovascular health among patients with diabetes: A cross‐sectional study	19
Association Between Arterial Stiffness and Bone Microarchitectural Deterioration in Type 2 Diabetes: A Cross‐Sectional Study	18
The Interaction Between Mitophagy Dysregulation and the Diabetic Bladder Microenvironment	18
	18
Association between follicle‐stimulating hormone and nonalcoholic fatty liver disease in postmenopausal women with type 2 diabetes mellitus	17
Evaluating the role of time in range as a glycemic target during short‐term intensive insulin therapy in patients with newly diagnosed type 2 diabetes	17
Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled, p	17
Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction	16
Beyond GLP ‐1	16
Association of obstructive sleep apnea symptoms with all‐cause mortality and cause‐specific mortality in adults with or without diabetes: A cohort study based on the NHANES	15
What is in a name and other peeves	15
Glucagon‐like‐peptide‐1 receptor agonists versus dipeptidyl peptidase‐4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide study	15
The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP‐1 Agonists: A Literature Review	15
Glucagon‐Like Peptide‐1 Receptor Agonists and Anesthesia—Are We Clearer on the Correct Approach?	15
Sleep Phenotypes, Genetic Susceptibility, and Risk of Obesity in Patients With Type 2 Diabetes: A National Prospective Cohort Study	14
	14
The Effectiveness of Psychological Interventions for Families of Children With Type 1 Diabetes on Caregiver and Child Functioning: A Systematic Review and Meta‐Analysis	14
Small steps forward: Adjunctive therapy for T1D	14
Remnant cholesterol is independently associated with diabetes, even if the traditional lipid is at the appropriate level: A report from the REACTION study	14
Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose–response meta‐analysis based on animal models	14
Developing a prediction model for all‐cause mortality risk among patients with type 2 diabetes mellitus in Shanghai, China	14
	13
Developmental origins of diabetes mellitus: Environmental epigenomics and emerging patterns	13
Acellular fish skin grafts in the treatment of diabetic wounds: Advantages and clinical translation	13
Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants	13
Advancing Diabetic Foot Ulcer Care: Focus on the Post‐Healing Transition Phase	13
Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena	13
Out of stock: A brief clinical reference for rough equivalency of glucagon‐like peptide‐1 (GLP‐1) ± glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists for A1c a	12
	12
Mitochondria‐associated membranes contribution to exercise‐mediated alleviation of hepatic insulin resistance: Contrasting high‐intensity interval training with moderate‐intensity continuous training	12
Optogenetic therapeutic strategies for diabetes mellitus	12
The World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)	12
Overcoming Missing Data: Accurately Predicting Cardiovascular Risk in Type 2 Diabetes, A Systematic Review	12
Author Response to the Comment on “Time Trends in Cardiovascular Event Incidence in New‐Onset Type 2 Diabetes: A Population‐Based Cohort Study From Germany”	12
Advancements and Challenges in Immune Protection Strategies for Islet Transplantation	12

Diabetes mellitus in stable chronic heart failure and the combination with humoral activation, their association, and prediction of 2‐year adverse outcomes. Data from the FARNHL	12
Clinical outcomes of obese and nonobese patients with atrial fibrillation according to associated metabolic abnormalities: A report from the COOL‐AF registry	12
No Evidence of Metabolomic Disruptions From Real‐World Intakes of Aspartame or Saccharin: The Coronary Artery Risk Development in Young Adults Study	12
DUALI China: Improved glycemic control withIDegLiraversus its individual components in a randomized trial with Chinese participants with type 2 diabetes uncontrolled on oral anti	12
Nailfold capillaroscopy and deep learning in diabetes	12
Establishing the China‐ SCO Cooperation Center for Metabolic Diseases to Build a Prevention and Control System for Metabolic Disorders, Advancing the	11
Obesity mediates the opposite association of education and diabetes in Chinese men and women: Results from the REACTION study	11
Are sodium‐glucose cotransporter‐2 inhibitors safe adjunctive drugs during insulin therapy in young children with type 1 diabetes? The first case of type 1 diabetes with SLC5A2 mutat	11
Longer leukocyte telomere length increases cardiovascular mortality in type 2 diabetes patients	11
Is There Any Difference in Preferences Between Patients and Physicians? Evidence From Anti‐Hyperglycemic Medications Choices for Type 2 Diabetes	11
Issue Information	11
Healthy Sleep Behaviors Reduce the Risk of Microvascular and Cardiovascular Complications in Patients With Type 2 Diabetes and Are Associated With Potential Serum Biomarkers: A UK Biobank O	11
Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional study	11
Commentary on the T1D exchange quality improvement collaborative learning session November 2022 abstracts	11
Issue Information	11
The potential adverse effects of hypodermic glucagon‐like peptide ‐1 receptor agonist on patients with type 2 diabetes: A population‐based study	11
Use of basal insulin in the management of adults with type 2 diabetes: An Asia‐Pacific evidence‐based clinical practice guideline	11
Commentary on “Pedal Medial Arterial Calcification in Diabetic Foot Ulcers: A Significant Risk Factor of Amputation and Mortality”	11
Diabetes and tuberculosis syndemic in India: A narrative review of facts, gaps in care and challenges	11
Increased prevalence of diabetes mellitus and its metabolic risk factors from 2002 to 2017 in Shanghai, China	11
Disease Progression Modeling of Estimated Glomerular Filtration Rate (eGFR): A Pharmacometrics Approach	10
Association between the stress–hyperglycemia ratio and all‐cause mortality in community‐dwelling populations: An analysis of the National Health and Nutrition Examination Survey (NHANES) 19	10
What was new at the 2023 American Diabetes Association meeting?	10
Sex Differences in the Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists for Weight Reduction: A Systematic Review and Meta‐Analysis	10
Local Versus Systemic Antibiotics for Diabetic Foot Infection—A Systematic Review and Meta‐Analysis	10
How can we reach the target of glucose control in type 1 diabetes?	10
Commentary on “Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry”	10
New Evidence, Creative Insights, and Strategic Solutions: Advancing the Understanding and Practice of Diabetes Osteoporosis	10
Diabesity phenotype in relation to the incidence and resolution of nonalcoholic fatty liver disease: A prospective cohort study	10
	10
Impact on glucometric variables and quality of life of the advanced hybrid closed‐loop system in pediatric and adolescent type 1 diabetes	10
National burden and risk factors of diabetes mellitus in China from 1990 to 2021: Results from the Global Burden of Disease study 2021	10
Healthy sleep score, acute myocardial infarction, and type 2 diabetes	9
Renal effects and safety between Asian and non‐Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists	9
Multimorbidity between Type 2 Diabetes and Depressive Symptoms in Mexico: Prevalence and Associated Factors From the Nationally Representative ENSANUT 2022 Survey	9
Yogliptin monotherapy in type 2 diabetes: A 12‐week randomized, double‐blind, placebo‐controlled phase II study	9
Plantar Tissue Characteristics in People With Diabetes With and Without Peripheral Neuropathy: A Novel Explanatory Model for DPN Risk Assessment	9
Issue Information	9
The 2023 WCIRDC: Obesity	9
Is fluoroscopy‐guided percutaneous bone biopsy of diabetic foot with suspected osteomyelitis worthwhile? A retrospective study	9
Major adverse cardiovascular events’ reduction and their association with glucose‐lowering medications and glycemic control among patients with type 2 diabetes: A retrospective cohort study using elec	9
Periodontal Disease: A Contributing Factor to Adverse Outcome in Diabetes	9
And the Dog Was Barking: Transforming Quality of Life in Diabetes Through Innovative Hypoglycemia Detection	9
Temporal associations of diabetes‐related complications with health‐related quality of life decrements in Chinese patients with type 2 diabetes: A prospective study among 19 322 adults—Joint Asia Diab	9
Lower urinary albumin‐to‐creatinine ratio predicted all‐cause and cardiovascular mortality in Chinese population with diabetes and prediabetes—The Shanghai Changfeng cohort study	9
Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long‐term risk of cardiovascular events and mortality	9
Efficacy of GLP‐1 Receptor Agonist‐Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta‐Analysis of Randomized Controlled Tr	9
November 14–15, 2023, T1DX‐QI Learning Session, Journal of Diabetes Abstracts	9
Issue Information	9
Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study	8
Antibody response to inactivated COVID‐19 vaccine in patients with type 2 diabetes mellitus after the booster immunization	8
Gut microbiota, serum metabolites, and lipids related to blood glucose control and type 1 diabetes	8
What will we see in diabetes in the next 10 years?	8
Recent Articles—Skeletal Muscle and Other Topics in Diabetes	8
Cardiovascular Therapy Benefits of Novel Antidiabetic Drugs in Patients With Type 2 Diabetes Mellitus Complicated With Cardiovascular Disease: A Network Meta‐Analysis	8
Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With	8
Comparative Analysis of AI Tools for Disseminating ADA 2025 Diabetes Care Standards: Implications for Cardiovascular Physicians	8
Electroacupuncture reduces blood glucose by regulating intestinal flora in type 2 diabetic mice	8
β‐Cell gene expression stress signatures in types 1 and 2 diabetes	8
Long‐Term or Recurrent Antibiotic Use in Early Life and the Risk of Type 2 Diabetes: A Population‐Based Prospective Cohort and a Case–Control Study	8
Issue Information	8
Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China	8
Follow‐up frequency and clinical outcomes in patients with type 2 diabetes: A prospective analysis based on multicenter real‐world data	8
Association Between Socioeconomic Status and the Prevalence of Metabolic Diseases: A Nationwide Cross‐Sectional Study in China	8
Issue Information	7
Issue Information	7
Comprehensive risk profiles of family history and lifestyle and metabolic risk factors in relation to diabetes: A prospective cohort study	7
Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: Long‐term follow‐up of the ESCAPE study	7
The relationship between well‐being and HbA1c in adults with type 1 diabetes: A systematic review	7
Trends, Social Determinants, and Lifestyle Factors Associated With Comorbidity of Diabetes and Kidney Diseases Among Chinese Adults Aged ≥ 45 Years	7
B Lymphocyte—A Prognostic Indicator in Post‐Acute Pancreatitis Diabetes Mellitus	7
Bioinformatic and rare‐variant collapsing analyses for type 1 and type 2 diabetes in the UK Biobank reveal novel pleiotropic susceptibility loci	7
Physical activity modifies the association between atherogenic index of plasma and prediabetes and diabetes: A cross‐sectional analysis	7
Clinical characteristics and complication risks in data‐driven clusters among Chinese community diabetes populations	7
Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: A multicenter, large sample survey	7
Diabetic Kidney Disease Update	7
	7
Impaired Cardiorespiratory Fitness in Type 1 Diabetes Is Associated With Metabolic Inflexibility and Specific Factors According to Sex	7
Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open‐Label, Active	7
Nonalcoholic fatty liver disease in relation to the remission and progression along the glycemic continuum	7

Identify Diagnostic Biomarkers Related to Taurine Metabolism in Diabetic Foot Ulcers Using Bulk RNA ‐seq and ScRNA‐seq Analysis	7
History of Hypertension From Childhood and Fasting Blood Glucose Levels in Adulthood: The Bogalusa Study	7